Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: A comparison with standard treatment.
Girardi P1, Rapinesi C, Chiarotti F, Kotzalidis GD, Piacentino D, Serata D, Del Casale A, Scatena P, Mascioli F, Raccah RN, Brugnoli R, Digiacomantonio V,Ferri VR, Ferracuti S, Zangen A, Angeletti G. World J Biol Psychiatry. 2014 Aug 20:1-8.
The study compared standard drug treatment (n=10) with drug treatment combined with Brainsway® Deep TMS (Transcranial Magnetic Stimulation ; n=10) for treating mood and substance use disorders through stimulation of the Dorsolateral prefrontal cortex (DLPFC). The study, held over 6 months, included abstinent patients suffering from Alcohol Use Disorder, who also had a previous dysthymic disorder.Read More
Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): A 6-month, open label, follow-up study
Chiara Rapinesi, Martina Curto, Georgios D. Kotzalidiscorrespondenceemail, Antonio Del Casale, Daniele Serata, Vittoria Rachele Ferri, Simone Di Pietro, Paola Scatena, Francesco Saverio Bersani, Ruggero Nessim Raccah, Vittorio Digiacomantonio, Stefano Ferracuti, Giuseppe Bersani, Abraham Zangen, Gloria Angeletti, Paolo Girardi. Published Online: November 20, 2014. Journal of affected disorders.
This study was designed to evaluate the effects of Brainsway® Deep TMS (Transcranial Magnetic Stimulation) in depression patients, with (n=11) or without (n=12) concomitant Alcohol Use Disorders (AUD). In the study, following 20 Deep TMS treatments, there was a substantial improvement of symptoms across groups, with faster improvement in patients who suffered from both depression and AUD. Significantly, these beneficial effects of the treatment were still visible at the 6-month follow-up.Read More
Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis
Kedzior, K. K., Gellersen, H. M., Brachetti, A. K., & Berlim, M. T. (2015). Journal of Affective Disorders, 187:73–83
This review and meta-analysis paper concerns the acute effect of Brainsway® Deep TMS (Deep Transcranial Magnetic Stimulation) on major depressive disorder (MDD). The review included 9 open label studies enrolling mostly treatment resistant MDD patients.Read More
Retrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson’s Disease
Torres F, Villalon E, Poblete P, Moraga-Amaro R, Linsambarth S, Riquelme R, Zangen A. and Stehberg J. Retrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson’s Disease. Front Neurol. 2015; 6: 210.The study examined the effectiveness of Brainsway® Deep TMS as an add-on treatment for Parkinson's patients who are regularly treated with medication but show insufficient response to the standard medications. The study included 45 Parkinson's patients, who underwent 14 sessions of Brainsway Deep TMS treatment over three weeks. Each treatment session included low-frequency stimulation (1 Hz) of the motor cortex (M1) for 15 minutes, immediately followed by high-frequency stimulation (10 Hz) of the lateral prefrontal cortex for an additional 15 minutes.Read More